Sam­sung Bi­o­log­ics and No­var­tis ink man­u­fac­tur­ing con­tract worth $81M

As Sam­sung Bi­o­log­ics, the biotech di­vi­sion of the Sam­sung Group, places more em­pha­sis on man­u­fac­tur­ing, the com­pa­ny is ink­ing a ma­jor new con­tract with No­var­tis …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER